Status: current, Defined. Date: 31-Dec 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2951651000168112 | Irinotecan Hydrochloride Trihydrate (Kabi) (irinotecan hydrochloride trihydrate 300 mg / 15 mL) injection, 1 x 15 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2951661000168114 | Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | Is a | irinotecan hydrochloride trihydrate 300 mg/15 mL injection, 15 mL vial | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | has TPUU | Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | true | Inferred relationship | Some | 1 | |
| Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | has TP | Irinotecan Hydrochloride Trihydrate (Kabi) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | Is a | True | Irinotecan Hydrochloride Trihydrate (Kabi) 300 mg/15 mL injection, 15 mL vial | Inferred relationship | Some |
Reference Sets
Unit of use quantity reference set
Trade product pack reference set
FHIR